Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04396821
Title A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Mabspace Biosciences (Suzhou) Co., Ltd.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Gilbert Arizona 85234 United States Details
University of Arizona Tucson Arizona 85724 United States Details
Yale University New Haven Connecticut 06519 United States Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Emory University Atlanta Georgia 30033 United States Details
University of Kansas, School of Medicine Kansas City Kansas 66160 United States Details
Washington University Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering New York New York 10065 United States Details
Stony Brook Cancer Center Stony Brook New York 11794 United States Details
Wake Forest Baptist Comprehensive Cancer Center Winston-Salem North Carolina 27157 United States Details
Gabrail Cancer Research Canton Ohio 44718 United States Details
Pennsylvania Cancer Specialist Research Institute Gettysburg Pennsylvania 17325 United States Details
Allegheny Hospital Pittsburgh Pennsylvania 15212 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Vanderbilt University Nashville Tennessee 37232 United States Details
NEXT Oncology Austin Texas 78704 United States Details
Swedish Cancer Institute Seattle Washington 98104 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field